Company

MetrioPharm AG is a publically listed Swiss biopharmaceutical company with headquarters in Zurich and its R&D Center in Hennigsdorf, near Berlin, Germany. The company focuses on the global scouting and validation of novel drug candidates, for which there already exists proof of efficacy and safety in man.

MetrioPharm follows a highly efficient development strategy by accumulating and maintaining core know-how within the company, but out-sourcing most of its experimental development tasks to specialized academic and/or contract research partners. Thus we can manage our R&D programs in a highly flexible and economic way, which is refelected by the lean setup of the company.